2019
DOI: 10.1016/j.jval.2019.04.603
|View full text |Cite
|
Sign up to set email alerts
|

Pdb54 Trends in Prices of Insulin Marketed in the Us

Abstract: In complex DFUs with exposed tendon, muscle or bone, the use of Neox was the less costly option to attain higher wound closure rates over the same time period. This was due to the fact that fewer Neox product applications were required. Prospective randomized controlled trials or manufacturer sponsored registries might be considered in order to verify these early results for this serious condition and unmet medical need.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles